GliaCure
Pioneering advancements in neurotherapies by harnessing the power of glial cells.
General Information
BounceWatch is an independent company data service, not affiliated with GliaCure. To contact GliaCure, visit gliacure.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does GliaCure compare?
A PDF of GliaCure and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting GliaCure soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About GliaCure
Business keywords: neurotherapies, glial cells, Boston, therapeutics, neurological disorders, neuropsychiatric conditions, drug development, biotech startups
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $1.58M | - |
|
04 Sep 2018 |
| Grant | $1.00M | - |
|
17 Mar 2015 |
| Series B | $5.80M | - |
|
04 Aug 2014 |
| Series A | $2.75M | - |
|
25 Apr 2012 |
GliaCure Alternatives & Competitors
View All Alternatives
Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases
Pioneering novel treatments for neurological diseases, advancing the way to effective remyelination...
Precision medicines to match the complexity of the human brain.
FAQ About GliaCure
Source: BounceWatch company record for GliaCure, https://bouncewatch.com/company/gliacure, updated 26 December 2024. When citing, please name BounceWatch and link this page.
